Haplotypes (129 cis) | Trans codon | n | Type 1 PrPSc | Type 2 PrPSc | Type 1 & 2 PrPSc | All PrPScTypes | ||||
---|---|---|---|---|---|---|---|---|---|---|
% | Disease duration | % | Disease duration | % types | Disease duration | Disease duration | Age at onset | |||
129 | type 1 | (mean ± SD; range) | type 2 | (months, mean ± SD; range) | 1 and 2 | (months, mean ± SD; range) | (months, mean ± SD; range) | (years mean ± SD; range) | ||
E200K-129V | ||||||||||
 | M | 7 | 0 | - | 86% | 8 ± 1 | 14% | 10 | 8 ± 1 | 56 ± 12 |
 |  |  |  |  | (n = 6) | (7–9) | (n = 1) |  | (7–10) | (37–67) |
 | V | 4 | 0 | - | 100% | 10 ± 6 | 0 | - | 10 ± 6 | 54 ± 12 |
 |  |  |  |  | (n = 4) | (2–17) | (2–17) | (37–66) | ||
All |  | 11 | 0 | - | 91% | 9 ± 4 | 8% | 10 | 9 ± 4 a | 55 ± 11 |
 |  |  |  |  | (10) | (2–17) | (n = 1) | (2–17) | (37–67) | |
E200K-129M | ||||||||||
 | M | 54 | 91% | 4 ± 2 | 0 | - | 9% | 4 ± 2 | 4 ± 2 b | 59 ± 11 |
 |  |  | (n = 49) | (1–12) |  |  | (n = 5) | (2–7) | (1–12) | (40–85) |
 | V | 19 | 47% | 5.5 ± 3 c | 26.5% | 16.5 ± 8 c | 26.5% | 7 ± 4 | 9 ± 7 b | 63 ± 7 |
 |  |  | (n = 9) | (3–10) | (n = 5) | (6.5-29) | (n = 5) | (2–11) | (2–29) | (53–76) |
All |  | 73 | 79% | 4 ± 2 | 7% | 16.5 ± 8 | 14% | 5 ± 3 | 5 ± 4.5 a | 60 ± 10 |
 |  | (n = 58) | (1–12) | (n = 5) | (6.5-29) | (n = 10) | (2–11) | (1–29) | (40–85) |